Cc1csc(Sc2ccc(C(=O)OCC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2[N+](=O)[O-])n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?